Scientific Advisory Boards: NONE NONE Gifts: NONE NONE Funding for Travel or Speaker Honoraria: NONE NONE Editorial Boards: NONE NONE
Patents: NONE NONE Publishing Royalties: NONE NONE Employment, Commercial Entity: NONE NONE Consultancies: NONE NONE Speakers' Bureaus: NONE
NONE Other Activities: NONE NONE Clinical Procedures or Imaging Studies: NONE NONE Research Support, Commercial Entities: NONE NONE Research
Support, Government Entities: NONE NONE Research Support, Academic Entities: NONE NONE Research Support, Foundations and Societies: NONE
NONE Stock/Stock Options/Board of Directors Compensation: NONE NONE License Fee Payments, Technology or Inventions: NONE NONE Royalty
Payments, Technology or Inventions: NONE NONE Stock/Stock Options, Research Sponsor: NONE NONE Stock/Stock Options, Medical Equipment &
Materials: NONE NONE Legal Proceedings: NONE NONE Scientific Advisory Boards: NONE NONE Gifts: NONE NONE Funding for Travel or Speaker
Honoraria: NONE NONE Editorial Boards: NONE NONE Patents: NONE NONE Publishing Royalties: NONE NONE Employment, Commercial Entity: NONE NONE
Consultancies: NONE NONE Speakers' Bureaus: NONE NONE Other Activities: NONE NONE Clinical Procedures or Imaging Studies: NONE NONE Research
Support, Commercial Entities: NONE NONE Research Support, Government Entities: NONE NONE Research Support, Academic Entities: NONE NONE
Research Support, Foundations and Societies: NONE NONE Stock/Stock Options/Board of Directors Compensation: NONE NONE License Fee Payments,
Technology or Inventions: NONE NONE Royalty Payments, Technology or Inventions: NONE NONE Stock/Stock Options, Research Sponsor: NONE NONE
Stock/Stock Options, Medical Equipment & Materials: NONE NONE Legal Proceedings: NONE NONE Scientific Advisory Boards: NONE NONE Gifts: NONE
NONE Funding for Travel or Speaker Honoraria: NONE NONE Editorial Boards: NONE NONE Patents: NONE NONE Publishing Royalties: NONE NONE
Employment, Commercial Entity: NONE NONE Consultancies: NONE NONE Speakers' Bureaus: NONE NONE Other Activities: NONE NONE Clinical
Procedures or Imaging Studies: NONE NONE Research Support, Commercial Entities: NONE NONE Research Support, Government Entities: My salary
is paid by the UK National Health Service for clinical and research duties. My salary is paid by the UK National Health Service for clinical
and research duties. Research Support, Academic Entities: NONE NONE Research Support, Foundations and Societies: NONE NONE Stock/Stock
Options/Board of Directors Compensation: NONE NONE License Fee Payments, Technology or Inventions: NONE NONE Royalty Payments, Technology or
Inventions: NONE NONE Stock/Stock Options, Research Sponsor: NONE NONE Stock/Stock Options, Medical Equipment & Materials: NONE NONE Legal
Proceedings: NONE NONE Scientific Advisory Boards: NONE NONE Gifts: NONE NONE Funding for Travel or Speaker Honoraria: NONE NONE Editorial
Boards: NONE NONE Patents: NONE NONE Publishing Royalties: NONE NONE Employment, Commercial Entity: NONE NONE Consultancies: NONE NONE
Speakers' Bureaus: NONE NONE Other Activities: NONE NONE Clinical Procedures or Imaging Studies: NONE NONE Research Support, Commercial
Entities: NONE NONE Research Support, Government Entities: NONE NONE Research Support, Academic Entities: NONE NONE Research Support,
Foundations and Societies: NONE NONE Stock/Stock Options/Board of Directors Compensation: NONE NONE License Fee Payments, Technology or
Inventions: NONE NONE Royalty Payments, Technology or Inventions: NONE NONE Stock/Stock Options, Research Sponsor: NONE NONE Stock/Stock
Options, Medical Equipment & Materials: NONE NONE Legal Proceedings: NONE NONE Scientific Advisory Boards: NONE NONE Gifts: NONE NONE
Funding for Travel or Speaker Honoraria: NONE NONE Editorial Boards: NONE NONE Patents: NONE NONE Publishing Royalties: NONE NONE
Employment, Commercial Entity: NONE NONE Consultancies: NONE NONE Speakers' Bureaus: NONE NONE Other Activities: NONE NONE Clinical
Procedures or Imaging Studies: NONE NONE Research Support, Commercial Entities: NONE NONE Research Support, Government Entities: NONE NONE
Research Support, Academic Entities: NONE NONE Research Support, Foundations and Societies: NONE NONE Stock/Stock Options/Board of Directors
Compensation: NONE NONE License Fee Payments, Technology or Inventions: NONE NONE Royalty Payments, Technology or Inventions: NONE NONE
Stock/Stock Options, Research Sponsor: NONE NONE Stock/Stock Options, Medical Equipment & Materials: NONE NONE Legal Proceedings: NONE NONE
Scientific Advisory Boards: NONE NONE Gifts: NONE NONE Funding for Travel or Speaker Honoraria: NONE NONE Editorial Boards: NONE NONE
Patents: NONE NONE Publishing Royalties: NONE NONE Employment, Commercial Entity: NONE NONE Consultancies: NONE NONE Speakers' Bureaus: NONE
NONE Other Activities: NONE NONE Clinical Procedures or Imaging Studies: NONE NONE Research Support, Commercial Entities: NONE NONE Research
Support, Government Entities: NONE NONE Research Support, Academic Entities: NONE NONE Research Support, Foundations and Societies: NONE
NONE Stock/Stock Options/Board of Directors Compensation: NONE NONE License Fee Payments, Technology or Inventions: NONE NONE Royalty
Payments, Technology or Inventions: NONE NONE Stock/Stock Options, Research Sponsor: NONE NONE Stock/Stock Options, Medical Equipment &
Materials: NONE NONE Legal Proceedings: NONE NONE Scientific Advisory Boards: I have served on scientific advisory boards for CSL Bering and
Octapharma. I have served on scientific advisory boards for CSL Bering and Octapharma. Gifts: NONE NONE Funding for Travel or Speaker
Honoraria: NONE NONE Editorial Boards: NONE NONE Patents: NONE NONE Publishing Royalties: NONE NONE Employment, Commercial Entity: NONE NONE
Consultancies: NONE NONE Speakers' Bureaus: NONE NONE Other Activities: NONE NONE Clinical Procedures or Imaging Studies: NONE NONE Research
Support, Commercial Entities: NONE NONE Research Support, Government Entities: NONE NONE Research Support, Academic Entities: NONE NONE
Research Support, Foundations and Societies: NONE NONE Stock/Stock Options/Board of Directors Compensation: NONE NONE License Fee Payments,
Technology or Inventions: NONE NONE Royalty Payments, Technology or Inventions: NONE NONE Stock/Stock Options, Research Sponsor: NONE NONE
Stock/Stock Options, Medical Equipment & Materials: NONE NONE Legal Proceedings: NONE NONE Scientific Advisory Boards: NONE NONE Gifts: NONE
NONE Funding for Travel or Speaker Honoraria: NONE NONE Editorial Boards: NONE NONE Patents: NONE NONE Publishing Royalties: NONE NONE
Employment, Commercial Entity: NONE NONE Consultancies: NONE NONE Speakers' Bureaus: NONE NONE Other Activities: NONE NONE Clinical
Procedures or Imaging Studies: NONE NONE Research Support, Commercial Entities: NONE NONE Research Support, Government Entities: NONE NONE
Research Support, Academic Entities: NONE NONE Research Support, Foundations and Societies: NONE NONE Stock/Stock Options/Board of Directors
Compensation: NONE NONE License Fee Payments, Technology or Inventions: NONE NONE Royalty Payments, Technology or Inventions: NONE NONE
Stock/Stock Options, Research Sponsor: NONE NONE Stock/Stock Options, Medical Equipment & Materials: NONE NONE Legal Proceedings: NONE NONE
Scientific Advisory Boards: NONE NONE Gifts: NONE NONE Funding for Travel or Speaker Honoraria: NONE NONE Editorial Boards: BRAIN, Associate
Editor 2004 BRAIN, Associate Editor 2004 Patents: NONE NONE Publishing Royalties: NONE NONE Employment, Commercial Entity: NONE NONE
Consultancies: NONE NONE Speakers' Bureaus: NONE NONE Other Activities: NONE NONE Clinical Procedures or Imaging Studies: NONE NONE Research
Support, Commercial Entities: NONE NONE Research Support, Government Entities: Medical Research Council (UK) Medical Research Council (UK)
Research Support, Academic Entities: NONE NONE Research Support, Foundations and Societies: Wellcome Trust Wellcome Trust Stock/Stock
Options/Board of Directors Compensation: NONE NONE License Fee Payments, Technology or Inventions: NONE NONE Royalty Payments, Technology or
Inventions: NONE NONE Stock/Stock Options, Research Sponsor: NONE NONE Stock/Stock Options, Medical Equipment & Materials: NONE NONE Legal
Proceedings: NONE NONE Primary familial basal ganglia calcification (PFBC) (previously known as idiopathic basal ganglia calcification or
Fahr disease) is an autosomal dominant neurodegenerative disorder characterized by bilateral cerebral calcification primarily affecting the
basal ganglia. Recently, mutations in SLC20A2,1 PDGFRB,2 and PDGFB3,4 have been identified as causing PFBC. However, other than the original
study,3 there has been a paucity of descriptions of families with PFBC.5 Herein, we describe 4 cases of PFBC within a family due to a novel
mutation in exon 4 of the PDGFB gene (c.C3657T:p.P122L) highlighting significant phenotypic heterogeneity. A 31-year-old woman presented
with acute psychosis. She was diagnosed in childhood with mild learning difficulties, but reached normal motor milestones. Over the next 6
years, she had recurrent episodes of psychosis and depression requiring admission. At age 36, a CT scan of her head revealed basal ganglia
calcification precipitating neurologic referral (figure, A.b). (A) CT and MRI scans of cases. (A.a) Case IV.4 (age 20 years): T2 MRI scan
with no evidence of calcium deposition within the basal ganglia. (A.b) Case III.2 (age 36 years): CT scan showing calcium deposition in the
caudate, lentiform nuclei, and thalamus. (A.c) Case III.5 (age 40 years): CT scan showing isolated subtle calcium deposition in the globus
pallidus. (A.d) Case II.4 (age 66 years): T1 MRI showing calcification in the globus pallidus together with periventricular and pontine
vascular white matter changes. (B) Pedigree of the family with the PDGFB p.P122L mutation. Black = affected individuals; clear = unaffected.
(C) Details of the mutation found in affected individuals. MAF = minor allele frequency. Examination revealed jerky ocular pursuit,
generalized chorea, and midline ataxia. Investigations revealed a normal full blood count, biochemistry, and autoantibodies. An EEG showed
no encephalopathic features. There was no family history of any neurologic disorder; however, the examining neurologist noted that the
patient's mother, accompanying her to clinic, was ataxic (patient II.4). A retired shop worker was referred aged 60 years (figure). Both
parents died in their 70s with no neurologic symptoms before death. She had 3 siblings, none of whom she remained in contact with. She had
episodic psychosis and depression for more than 20 years, and a 2-year history of falls and unsteady gait. Medical history included
hypertension and heavy smoking. Examination revealed a severe midline ataxia with jerky ocular pursuit. There were no cognitive
abnormalities or extrapyramidal features. Serum biochemistry (including calcium and phosphate) was normal. A muscle biopsy showed normal
histology, normal mitochondrial biochemical studies, and no mitochondrial DNA deletions. An EEG revealed transient sharp waves in the
temporal regions. MRI showed calcium deposition in the globus pallidus and dentate (figure, A.d). Over the next 5 years, her ataxia
progressed but cognition remained normal (Mini-Mental State Examination score 28/30 at age 66). A woman aged 40 years was referred with a
2-year history of gait disturbance. She had no psychiatric history, cognitive symptoms, or evidence of abnormal movements. Examination
revealed normal cognition, but a midline ataxia. A CT brain scan showed bilateral calcification of the globus pallidus (figure, A.c). Three
years later, she developed a complex motor tic, and dystonic posturing of both feet. Formal neuropsychometry remained normal. A 20-year-old
woman was referred with a gait disturbance. She had no other medical or psychiatric history. Neurologic examination was normal. Brain MRI
revealed small frontal noncalcified white matter changes not in keeping with PFBC, and no evidence of calcium in the basal ganglia even with
susceptibility-weighted imaging (figure, A.a). Aged 42 and 46 years, respectively, patients III.1 and III.4 were clinically unaffected.
Patient III.1 died of a traumatic injury with no evidence of basal ganglia calcification at autopsy. Patient III.4 refused imaging studies.
Whole-exome sequencing was performed on patients III.2, II.4, III.5, and IV.4 (appendix e-1 on the NeurologyÂ® Web site at Neurology.org)
revealing a shared novel missense mutation in exon 4 of PDGFB (c.C3657T:p.P122L), not seen in the 1000 Genomes or ESP6500 database (figure,
C), and predicted to be pathogenic by 4 software programs and conserved across all species (MutationTaster). This mutation was confirmed
present in cases and absent in unaffected relatives with Sanger sequencing (III.1 and III.4). The p.P122L mutation is in the same exon as
published pathogenic alleles.3,6 These cases highlight the phenotypic heterogeneity of mutations in PDGFB. Two patients exhibited an early
psychiatric phenotype followed by late-onset ataxia or chorea; an isolated movement disorder was identified in a third. All 3 had ataxia,
which has been described in isolated cases,5 but not consistently in PDGFB families.3 In addition, the ataxia in our cases occurred without
obvious cerebellar calcification. This suggests that (1) the mechanism may not be primarily mediated by calcium deposition (although we
cannot exclude the presence of microcalcification), and (2) there is significant clinical overlap with common neurologic and psychiatric
disorders.5 Our data also show a heterogeneous radiologic phenotype that may be much milder than previously described,3 and similar to
PDGFRB families.7 In keeping with this, case IV.4 showed no basal ganglia calcification and a normal neurologic examination at age 20 years,
providing the first evidence of potential incomplete radiologic penetrance for a pathogenic PDGFB mutation, highlighting that normal imaging
does not exclude the diagnosis of PFBC. Supplemental data at Neurology.org Author contributions: M.J. Keogh: study concept and design,
analysis and interpretation of data, acquisition of data, statistical analysis, drafting/revising the manuscript. A. Pyle: analysis and
interpretation of data, statistical analysis. D. Daud: analysis or interpretation of data, acquisition of data, drafting manuscript for
content. H. Griffin: statistical analysis. K. Douroudis: statistical analysis. G. Eglon: acquisition of data. J. Miller: acquisition of
data, drafting the manuscript. R. Horvath: study concept and design. P.F. Chinnery: study concept and design, analysis and interpretation of
data, study supervision, drafting the manuscript. Study funding: Dr. Michael Keogh is a Wellcome Trust Clinical Research Training Fellow.
Prof. Horvath is supported by the Medical Research Council (UK) (G1000848) and the European Research Council (309548). Prof. Chinnery is a
Wellcome Trust Senior Fellow in Clinical Science and National Institute for Health Research Senior Investigator. He receives funding from
the Medical Research Council and the National Institute for Health Research Biomedical Research Centre for Ageing and Age-Related Disease
award to the Newcastle Upon Tyne Foundation Hospitals National Health Service Trust. Disclosure: The authors report no disclosures relevant
to the manuscript. Go to Neurology.org for full disclosures. The Article Processing Charge was paid by Wellcome Trust.
